When comparing liver CD34 staining in patients without MASH and with MASH, we observed that patients with MASH had a higher density of CD34 positive vessels (Fig. 1C, p <0.05) and a higher rate of CD34 staining in the lobular area (Fig. 1E, p <0.05), but not in the periportal area (Fig. 1D). The gene discussed is CD34; the disease is metabolic dysfunction-associated steatohepatitis.